文献速递头颈外科

头颈部皮肤血管肉瘤的治疗模式与生存分析

Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-02-11

基于美国国家癌症数据库2004–2015年693例头颈部皮肤血管肉瘤患者的回顾性队列研究,其中421例接受根治性治疗且数据完整者纳入生存分析。中位随访29个月,3年生存率为50.1%;多因素分析显示年龄≥75岁和切缘阳性为总生存较差的独立预测因素。

要点

  • 头颈部皮肤血管肉瘤多见于老年男性,中位年龄77岁。
  • 年龄≥75岁和切缘阳性与更差的总生存独立相关。

核心结论

  • 头颈部血管肉瘤是影响老年人的罕见恶性肿瘤,手术且切缘阴性者生存改善。
  • 即使接受根治性多模式治疗,年龄≥75岁患者生存仍有限。

研究设计与样本

  • 回顾性队列研究,数据来自美国国家癌症数据库。
  • 查询2004–2015年头颈部皮肤血管肉瘤患者,共693例。
  • 生存分析仅纳入接受根治性治疗且数据完整的421例(60.8%)。
  • 采用单因素和多因素Cox回归分析预后因素。

主要发现

  • 693例中男性489例(70.6%),中位年龄77岁。
  • 421例生存分析队列的治疗分布:手术+放疗178例(42.3%)、单纯手术138例(32.8%)、三联治疗48例(11.4%)、手术+化疗29例(6.9%)、放化疗28例(6.7%)。
  • 中位随访29个月,3年生存率为50.1%。

临床怎么用

  • 对可切除的头颈部皮肤血管肉瘤,应优先争取手术并确保切缘阴性以改善生存。
  • 对年龄≥75岁患者,需综合评估根治性多模式治疗的获益与风险。

局限性

  • 回顾性研究设计,存在选择偏倚和信息偏倚可能。
  • 生存分析仅纳入421例(60.8%)接受根治性治疗且数据完整者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the patterns of care and survival of cutaneous angiosarcomas of the head and neck. STUDY DESIGN: Retrospective cohort study. SETTING: National Cancer Database. METHODS: The National Cancer Database was queried to select patients with cutaneous angiosarcoma of the head and neck between 2004 and 2015. For survival analysis, patients were included only if they received definitive treatment and complete data. Prognostic factors were analyzed by univariate and multivariable Cox regression. RESULTS: We identified 693 patients diagnosed with head and neck angiosarcomas during the study period. The majority were male (n = 489, 70.6%) and elderly (median, 77 years). A total of 421 patients (60.8%) met the criteria for survival analyses. These patients were treated with surgery and radiation (n = 178, 42.3%), surgery alone (n = 138, 32.8%), triple-modality therapy (n = 48, 11.4%), surgery and chemotherapy (n = 29, 6.9%), and chemoradiation (n = 28, 6.7%). With a median follow-up of 29 months, the 3-year survival was 50.1%. Patients undergoing surgery had better median survival than those who did not (38.1 vs 21.0 months, P = .04). Age, comorbidity, tumor size, and surgical margins were significant factors in univariate analyses. On multivariable analysis, age ≥75 years (hazard ratio, 2.65; 95% CI, 1.80-3.88; P < .001) and positive margins (hazard ratio, 1.91; 95% CI, 1.44-2.51; P < .001) predicted worse overall survival. CONCLUSION: Angiosarcoma of head and neck is a rare malignancy that affects the elderly. Surgical treatment with negative margins is associated with improved survival. Even with curative-intent multimodality treatment, the survival of patients aged ≥75 years is limited.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Chang C, Wu SP, Hu K, et al. Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck. Otolaryngol Head Neck Surg. 2020. PMID: 32043919. doi:10.1177/0194599820905495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。